LAUSR

Protein tyrosine phosphatase non‐receptor type 21 (PTPN21) is a member of the non‐receptor tyrosine phosphatase family. We have found that PTPN21 is mutated in relapsed Philadelphia chromosome‐negative acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation. PTPN21 consists of three types of isoforms according to the length of the protein encoded. However, the roles of different isoforms in leukemic cells have not been elucidated. In the study, PTPN21 isoform constitution in five ALL cell lines were identified by transcriptome polymerase chain reaction combined with Sanger sequencing, and the relationship between PTPN21 isoforms and sensitivity to natural killer (NK) cells mediated killing in ALL cell lines were further assessed by knock‐out of different isoforms of PTPN21 using CRISPR‐Cas9 technique. Subsequently, we explored the functional mechanisms through RNA sequencing and confirmatory testing. The results showed that there was no significant change when all PTPN21 isoforms were knocked out in ALL cells, but the sensitivity of NALM6 cells with PTPN21‐CDSlong knock‐out (NALM6‐PTPN21lk) to NK‐mediated killing was significantly increased. Whole transcriptome sequencing and further validation testing showed that human leukocyte antigen class I (HLA‐I) molecules were significantly decreased, accompanied by a significantly downregulated expression of antigen presenting‐related chaperones in NALM6‐PTPN21lk cells. Our results uncovered a previously unknown mechanism that PTPN21‐CDSlong and CDSshort isoforms may play opposite roles in NK‐mediated killing in ALL cells, and showed that the endogenous PTPN21‐CDSlong isoform inhibited ALL cells to NK cell‐mediated lysis by regulating the KIR‐HLA‐I axis.